Steven H. Collis - Nov 9, 2021 Form 4 Insider Report for AMERISOURCEBERGEN CORP (ABC)

Role
Chairman, President & CEO, Director
Signature
/s/ John G. Chou, attorney-in-fact for Steven H. Collis
Stock symbol
ABC
Transactions as of
Nov 9, 2021
Transactions value $
-$1,612,115
Form type
4
Date filed
11/12/2021, 03:42 PM
Previous filing
Oct 14, 2021
Next filing
Nov 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABC Common Stock Options Exercise $1.26M +12.8K +6.93% $98.24 197K Nov 9, 2021 Direct
transaction ABC Common Stock Options Exercise $868K +11.5K +5.82% $75.61 209K Nov 9, 2021 Direct
transaction ABC Common Stock Sale -$3.04M -24.3K -11.62% $125.33 185K Nov 9, 2021 Direct
transaction ABC Common Stock Options Exercise +12.7K +6.89% 197K Nov 10, 2021 Direct F1
transaction ABC Common Stock Tax liability -$695K -5.53K -2.8% $125.68 192K Nov 10, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABC Non-qualified Stock Option (Right to Buy) Options Exercise $0 -11.5K -6.25% $0.00 172K Nov 9, 2021 Common Stock 11.5K $75.61 Direct F2, F3
transaction ABC Non-qualified Stock Option (Right to Buy) Options Exercise $0 -12.8K -25% $0.00 38.4K Nov 9, 2021 Common Stock 12.8K $98.24 Direct F4
transaction ABC Restricted Stock Units Options Exercise $0 -12.7K -33.33% $0.00 25.4K Nov 10, 2021 Common Stock 12.7K $0.00 Direct F1
transaction ABC Restricted Stock Units Award +35.8K 35.8K Nov 10, 2021 Common Stock 35.8K $0.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023.
F2 The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21.
F3 Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20.
F4 Exerciseable in four equal annual installments on 11/11/16, 11/11/17, 11/11/18 and 11/11/19.
F5 Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024.